This work was supported by grants from the National Natural Science Foundation of China.No. (39730420). ** To whom requests for reprints should be addressed.This is one of papers of the special issue on gene...This work was supported by grants from the National Natural Science Foundation of China.No. (39730420). ** To whom requests for reprints should be addressed.This is one of papers of the special issue on gene therapy research (Chin J Cancer Res Vol. 9 No. 4 December, 1997). Vascular cell adhesion molecule 1 (VCAM 1) is a member of immunoglobulin superfamily. The principal ligand for VCAM 1 is integrin α4β1/VLA 4 (very late antigen 4). It was reported that VCAM 1 was expressed on macrophages and dendritic cells, but little is known about its function on these professional antigen pre senting cells (APC). The present study was performed to investigate the expression of VCAM 1 on macrophages and the role of VCAM 1/VLA 4 in the activation of allogenic T cells by murine macrophages. We analyzed VCAM 1 expression on peritoneal macrophages and macrophage cell line J774A.1 by fluorescence activated cell sorting (FACS). Using neutralizing antibodies, we further analyzed the role of VCAM 1/VLA 4 interaction in macrophage and allogenic T cell mixed lymphocyte reaction (MLR). We found that VCAM 1 was consti tutively expressed on macrophages and its expression level was upregulated by soluble tumor associated antigen (freeze thaw lysates of FBL 3 leukemia cells) and TNF α. In MLR assays, we observed that blocking VCAM 1/VLA 4 interaction with anti VCAM 1 or anti VLA 4 mAbs caused significant inhibition of the proliferative response and IL 2 production. These results suggest that VCAM 1on macrophages not only facilitates the cell to cell contact through adhesive interaction but also plays a role in the costimulation of T cells via its interaction with VLA 4 on the T cells.展开更多
文摘This work was supported by grants from the National Natural Science Foundation of China.No. (39730420). ** To whom requests for reprints should be addressed.This is one of papers of the special issue on gene therapy research (Chin J Cancer Res Vol. 9 No. 4 December, 1997). Vascular cell adhesion molecule 1 (VCAM 1) is a member of immunoglobulin superfamily. The principal ligand for VCAM 1 is integrin α4β1/VLA 4 (very late antigen 4). It was reported that VCAM 1 was expressed on macrophages and dendritic cells, but little is known about its function on these professional antigen pre senting cells (APC). The present study was performed to investigate the expression of VCAM 1 on macrophages and the role of VCAM 1/VLA 4 in the activation of allogenic T cells by murine macrophages. We analyzed VCAM 1 expression on peritoneal macrophages and macrophage cell line J774A.1 by fluorescence activated cell sorting (FACS). Using neutralizing antibodies, we further analyzed the role of VCAM 1/VLA 4 interaction in macrophage and allogenic T cell mixed lymphocyte reaction (MLR). We found that VCAM 1 was consti tutively expressed on macrophages and its expression level was upregulated by soluble tumor associated antigen (freeze thaw lysates of FBL 3 leukemia cells) and TNF α. In MLR assays, we observed that blocking VCAM 1/VLA 4 interaction with anti VCAM 1 or anti VLA 4 mAbs caused significant inhibition of the proliferative response and IL 2 production. These results suggest that VCAM 1on macrophages not only facilitates the cell to cell contact through adhesive interaction but also plays a role in the costimulation of T cells via its interaction with VLA 4 on the T cells.
